Title of Invention	MODIFIED RELEASE PHARMACEUTICAL FORMULATION
Abstract	The use of amoxycillin and clavulanate in the manufacture of a medicament for treating bacterial infections in humans, such that administration of the medicament provides from 1900 to 2600 mg of amoxycillin and an amount of potassium clavulanate such that the weight ratio of amoxycillin to potassium clavulanate is from 2:1 to 20:1, at intervals of about 12h.

Full Text	FORM 2 THE PATENTS ACT 1970 [39 OF 1970] & THE PATENTS RULES, 2003 COMPLETE SPECIFICATION [See Section 10; rule 13] "MODIFIED RELEASE PHARMACEUTICAL FORMULATION" BEECHAM PHARMACEUTICALS (PTE) LIMITED, A Singaporean company, of 38, Quality Road, Jurong Industrial Estate, Jurong, Singapore 618809

Documents:

abstract1.jpg

in-pct-2001-01199-mum-cancelled pages(1-10-2001).pdf

IN-PCT-2001-01199-MUM-CANCELLED PAGES(5-9-2007).pdf

IN-PCT-2001-01199-MUM-CLAIMS(1-10-2001).pdf

in-pct-2001-01199-mum-claims(granted)-(05-09-2007).doc

in-pct-2001-01199-mum-claims(granted)-(5-9-2007).pdf

IN-PCT-2001-01199-MUM-CLAIMS(GRANTED)-(6-11-2007).pdf

IN-PCT-2001-01199-MUM-CLAIMS(MARKED COPY)-(5-9-2007).pdf

IN-PCT-2001-01199-MUM-CORRESPONDENCE 1(21-5-2009).pdf

IN-PCT-2001-01199-MUM-CORRESPONDENCE 2(6-1-2011).pdf

IN-PCT-2001-01199-MUM-CORRESPONDENCE 3(26-3-2009).pdf

in-pct-2001-01199-mum-correspondence(1-10-2007).pdf

IN-PCT-2001-01199-MUM-CORRESPONDENCE(17-5-2010).pdf

IN-PCT-2001-01199-MUM-CORRESPONDENCE(6-1-2011).pdf

IN-PCT-2001-01199-MUM-CORRESPONDENCE(8-6-2010).pdf

IN-PCT-2001-01199-MUM-CORRESPONDENCE(IPO)-(21-1-2008).pdf

IN-PCT-2001-01199-MUM-CORRESPONDENCE(IPO)-(21-5-2010).pdf

in-pct-2001-01199-mum-correspondence(ipo)-(27-9-2006).pdf

IN-PCT-2001-01199-MUM-DESCRIPTION(COMPLETE)-(1-10-2001).pdf

IN-PCT-2001-01199-MUM-DESCRIPTION(GRANTED)-(6-11-2007).pdf

IN-PCT-2001-01199-MUM-DRAWING(1-10-2001).pdf

in-pct-2001-01199-mum-drawing(5-9-2007).pdf

IN-PCT-2001-01199-MUM-DRAWING(AMENDED)-(5-9-2007).pdf

IN-PCT-2001-01199-MUM-DRAWING(GRANTED)-(6-11-2007).pdf

IN-PCT-2001-01199-MUM-FORM 1(1-10-2001).pdf

IN-PCT-2001-01199-MUM-FORM 1(14-9-2007).pdf

in-pct-2001-01199-mum-form 1(5-9-2007).pdf

in-pct-2001-01199-mum-form 13(5-9-2007).pdf

IN-PCT-2001-01199-MUM-FORM 13(6-1-2011).pdf

IN-PCT-2001-01199-MUM-FORM 13(8-6-2010).pdf

in-pct-2001-01199-mum-form 18(15-12-2005).pdf

IN-PCT-2001-01199-MUM-FORM 2(COMPLETE)-(1-10-2001).pdf

in-pct-2001-01199-mum-form 2(granted)-(05-09-2007).doc

in-pct-2001-01199-mum-form 2(granted)-(5-9-2007).pdf

IN-PCT-2001-01199-MUM-FORM 2(GRANTED)-(6-11-2007).pdf

IN-PCT-2001-01199-MUM-FORM 2(TITLE PAGE)-(1-10-2001).pdf

IN-PCT-2001-01199-MUM-FORM 2(TITLE PAGE)-(GRANTED)-(6-11-2007).pdf

IN-PCT-2001-01199-MUM-FORM 26(17-5-2010).pdf

in-pct-2001-01199-mum-form 3(1-10-2001).pdf

in-pct-2001-01199-mum-form 3(5-9-2007).pdf

in-pct-2001-01199-mum-form 5(5-9-2007).pdf

in-pct-2001-01199-mum-form-pct-ipea-409(16-10-2000).pdf

IN-PCT-2001-01199-MUM-GENERAL POWER OF ATTORNEY(6-1-2011).pdf

IN-PCT-2001-01199-MUM-PETITION UNDER RULE 137(26-3-2009).pdf

in-pct-2001-01199-mum-petition under rule 137(5-9-2007).pdf

in-pct-2001-01199-mum-petition under rule 138(14-9-2007).pdf

in-pct-2001-01199-mum-petition under rule 138(5-9-2007).pdf

IN-PCT-2001-01199-MUM-POST-GRANT-OPPOSITION(27-1-2009).pdf

in-pct-2001-01199-mum-power of authority(27-9-2007).pdf

IN-PCT-2001-01199-MUM-SPECIFICATION(AMENDED)-(5-9-2007).pdf

IN-PCT-2001-01199-MUM-WO INTERNATIONAL PUBLICATION REPORT(1-10-2001).pdf